209 related articles for article (PubMed ID: 31544063)
1. CT-Based Radiomics Signature for the Preoperative Discrimination Between Head and Neck Squamous Cell Carcinoma Grades.
Wu W; Ye J; Wang Q; Luo J; Xu S
Front Oncol; 2019; 9():821. PubMed ID: 31544063
[No Abstract] [Full Text] [Related]
2. Magnetic resonance imaging based radiomics signature for the preoperative discrimination of stage I-II and III-IV head and neck squamous cell carcinoma.
Ren J; Tian J; Yuan Y; Dong D; Li X; Shi Y; Tao X
Eur J Radiol; 2018 Sep; 106():1-6. PubMed ID: 30150029
[TBL] [Abstract][Full Text] [Related]
3. Dual-energy CT-based radiomics nomogram in predicting histological differentiation of head and neck squamous carcinoma: a multicenter study.
Li Z; Liu Z; Guo Y; Wang S; Qu X; Li Y; Pan Y; Zhang L; Su D; Yang Q; Tao X; Yue Q; Xian J
Neuroradiology; 2022 Feb; 64(2):361-369. PubMed ID: 34860278
[TBL] [Abstract][Full Text] [Related]
4. A CT-Based Deep Learning Radiomics Nomogram to Predict Histological Grades of Head and Neck Squamous Cell Carcinoma.
Zheng YM; Che JY; Yuan MG; Wu ZJ; Pang J; Zhou RZ; Li XL; Dong C
Acad Radiol; 2023 Aug; 30(8):1591-1599. PubMed ID: 36460582
[TBL] [Abstract][Full Text] [Related]
5. A CT-based radiomics signature for preoperative discrimination between high and low expression of programmed death ligand 1 in head and neck squamous cell carcinoma.
Zheng YM; Zhan JF; Yuan MG; Hou F; Jiang G; Wu ZJ; Dong C
Eur J Radiol; 2022 Jan; 146():110093. PubMed ID: 34890937
[TBL] [Abstract][Full Text] [Related]
6. A computed tomography-based radiomics signature for predicting expression of programmed death ligand 1 in head and neck squamous cell carcinoma.
Zheng YM; Yuan MG; Zhou RQ; Hou F; Zhan JF; Liu ND; Hao DP; Dong C
Eur Radiol; 2022 Aug; 32(8):5362-5370. PubMed ID: 35298679
[TBL] [Abstract][Full Text] [Related]
7. Development and multicenter validation of a CT-based radiomics signature for discriminating histological grades of pancreatic ductal adenocarcinoma.
Chang N; Cui L; Luo Y; Chang Z; Yu B; Liu Z
Quant Imaging Med Surg; 2020 Mar; 10(3):692-702. PubMed ID: 32269929
[TBL] [Abstract][Full Text] [Related]
8. A multi-objective radiomics model for the prediction of locoregional recurrence in head and neck squamous cell cancer.
Wang K; Zhou Z; Wang R; Chen L; Zhang Q; Sher D; Wang J
Med Phys; 2020 Oct; 47(10):5392-5400. PubMed ID: 32657426
[TBL] [Abstract][Full Text] [Related]
9. Radiomics signature: a biomarker for the preoperative discrimination of lung invasive adenocarcinoma manifesting as a ground-glass nodule.
Fan L; Fang M; Li Z; Tu W; Wang S; Chen W; Tian J; Dong D; Liu S
Eur Radiol; 2019 Feb; 29(2):889-897. PubMed ID: 29967956
[TBL] [Abstract][Full Text] [Related]
10. Application of contrast-enhanced CT radiomics in prediction of early recurrence of locally advanced oesophageal squamous cell carcinoma after trimodal therapy.
Tang S; Ou J; Liu J; Wu YP; Wu CQ; Chen TW; Zhang XM; Li R; Tang MJ; Yang LQ; Tan BG; Lu FL; Hu J
Cancer Imaging; 2021 May; 21(1):38. PubMed ID: 34039403
[TBL] [Abstract][Full Text] [Related]
11. Predictive and prognostic value of CT based radiomics signature in locally advanced head and neck cancers patients treated with concurrent chemoradiotherapy or bioradiotherapy and its added value to Human Papillomavirus status.
Ou D; Blanchard P; Rosellini S; Levy A; Nguyen F; Leijenaar RTH; Garberis I; Gorphe P; Bidault F; Ferté C; Robert C; Casiraghi O; Scoazec JY; Lambin P; Temam S; Deutsch E; Tao Y
Oral Oncol; 2017 Aug; 71():150-155. PubMed ID: 28688683
[TBL] [Abstract][Full Text] [Related]
12. Predicting the grade of hepatocellular carcinoma based on non-contrast-enhanced MRI radiomics signature.
Wu M; Tan H; Gao F; Hai J; Ning P; Chen J; Zhu S; Wang M; Dou S; Shi D
Eur Radiol; 2019 Jun; 29(6):2802-2811. PubMed ID: 30406313
[TBL] [Abstract][Full Text] [Related]
13. A Radiomics Signature in Preoperative Predicting Degree of Tumor Differentiation in Patients with Non-small Cell Lung Cancer.
Chen X; Fang M; Dong D; Wei X; Liu L; Xu X; Jiang X; Tian J; Liu Z
Acad Radiol; 2018 Dec; 25(12):1548-1555. PubMed ID: 29572049
[TBL] [Abstract][Full Text] [Related]
14. CT-based radiomics signature: a potential biomarker for preoperative prediction of early recurrence in hepatocellular carcinoma.
Zhou Y; He L; Huang Y; Chen S; Wu P; Ye W; Liu Z; Liang C
Abdom Radiol (NY); 2017 Jun; 42(6):1695-1704. PubMed ID: 28180924
[TBL] [Abstract][Full Text] [Related]
15. Preoperative prediction for pathological grade of hepatocellular carcinoma via machine learning-based radiomics.
Mao B; Zhang L; Ning P; Ding F; Wu F; Lu G; Geng Y; Ma J
Eur Radiol; 2020 Dec; 30(12):6924-6932. PubMed ID: 32696256
[TBL] [Abstract][Full Text] [Related]
16. Computed Tomography-Based Radiomics Signature: A Potential Indicator of Epidermal Growth Factor Receptor Mutation in Pulmonary Adenocarcinoma Appearing as a Subsolid Nodule.
Yang X; Dong X; Wang J; Li W; Gu Z; Gao D; Zhong N; Guan Y
Oncologist; 2019 Nov; 24(11):e1156-e1164. PubMed ID: 30936378
[TBL] [Abstract][Full Text] [Related]
17. Computed Tomography Radiomics Predicts HPV Status and Local Tumor Control After Definitive Radiochemotherapy in Head and Neck Squamous Cell Carcinoma.
Bogowicz M; Riesterer O; Ikenberg K; Stieb S; Moch H; Studer G; Guckenberger M; Tanadini-Lang S
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(4):921-928. PubMed ID: 28807534
[TBL] [Abstract][Full Text] [Related]
18. Clinical application of CT-based radiomics model in differentiation between laryngeal squamous cell carcinoma and squamous cell hyperplasia.
Cui F; Khodrog OA; Liu W; Liu J; Yuan Q
Front Med (Lausanne); 2023; 10():1337723. PubMed ID: 38274455
[TBL] [Abstract][Full Text] [Related]
19. Radiomics of apparent diffusion coefficient maps to predict histologic grade in squamous cell carcinoma of the oral tongue and floor of mouth: a preliminary study.
Ren J; Qi M; Yuan Y; Tao X
Acta Radiol; 2021 Apr; 62(4):453-461. PubMed ID: 32536260
[TBL] [Abstract][Full Text] [Related]
20. CT-based radiomics signatures can predict the tumor response of non-small cell lung cancer patients treated with first-line chemotherapy and targeted therapy.
Yang F; Zhang J; Zhou L; Xia W; Zhang R; Wei H; Feng J; Zhao X; Jian J; Gao X; Yuan S
Eur Radiol; 2022 Mar; 32(3):1538-1547. PubMed ID: 34564744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
